His research as co-director of the Australian Melanoma Institute is based on immunotherapy, a treatment method in which the body’s immune system attacks cancer cells. This treatment works very well for melanoma patients, and now they decided to test it on their type of cancer, which had a very poor prognosis.
Advertisement
Thus, Skoyler became the first brain cancer patient to receive combination immunotherapy before surgery, and the first to receive a personalized vaccine based on the characteristics of his tumor.
“It doesn’t mean my brain cancer is cured …. but it’s nice to know it hasn’t come back yet, I still have more time to enjoy life with my wife Kathy and three wonderful children,” he acknowledged.
This milestone in treatment is hope for the more than 300,000 people diagnosed with brain cancer worldwide each year.
